Related Experiment Video
Updated: Nov 26, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
The prevalence and incidence of glaucoma in Norway 2004-2018: A nationwide population-based study
Jon Klokk Slettedal1,2, Valgerður Dóra Traustadóttir1, Leiv Sandvik3
1Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Purpose:
To describe prevalence, life-time prevalence and incidence of glaucoma in Norway over a 15-year period.
Materials And Methods:
Data from The Norwegian Prescription Database was used to identify all prescriptions for glaucoma medication during the period 2004 to 2018. Population figures and lifespan data were obtained from The National Bureau of Statistics.
Results:
Of a population of 5.3 million, a total of 75733 patients using glaucoma eye drops were identified in 2018. The national prevalence was thus 1.4%, whilst in those over 70 years of age, 8.0%. When divided into counties, the prevalence varied between 1.1 and 1.9%. Overall, the prevalence was stable in the period 2004-2018. Life time prevalence was found to be 9.4% for men and 10.2% for women. National one-year incidence proportion per 10000 was 17.0 for the total population and a peak incidence of 93.8/10000 in the 80-89 year age group was identified.
Conclusions:
Glaucoma prevalence remained stable during the period 2004-2018, while incidence decreased slightly in the elderly population.
Related Concept Videos
Glaucoma: Overview
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

